|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rakha EA, Reis-Filho JS and Ellis IO:
Basal-like breast cancer: A critical review. J Clin Oncol.
26:2568–2581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jamdade VS, Sethi N, Mundhe NA, Kumar P,
Lahkar M and Sinha N: Therapeutic targets of triple-negative breast
cancer: A review. Br J Pharmacol. 172:4228–4237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soady KJ, Kendrick H, Gao Q, Tutt A,
Zvelebil M, Ordonez LD, Quist J, Tan DW, Isacke CM, Grigoriadis A
and Smalley MJ: Mouse mammary stem cells express prognostic markers
for triple-negative breast cancer. Breast Cancer Res. 17:312015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chiotaki R, Polioudaki H and
Theodoropoulos PA: Stem cell technology in breast cancer: Current
status and potential applications. Stem Cells Cloning. 9:17–29.
2016.PubMed/NCBI
|
|
8
|
Jiang P and Zhang D: Maternal embryonic
leucine zipper kinase (MELK): A novel regulator in cell cycle
control, embryonic development, and cancer. Int J Mol Sci.
14:21551–21560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Janostiak R, Rauniyar N, Lam TT, Ou J, Zhu
LJ, Green MR and Wajapeyee N: MELK promotes melanoma growth by
stimulating the NF-κB pathway. Cell Rep. 21:2829–2841. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakano I, Masterman-Smith M, Saigusa K,
Paucar AA, Horvath S, Shoemaker L, Watanabe M, Negro A, Bajpai R,
Howes A, et al: Maternal embryonic leucine zipper kinase is a key
regulator of the proliferation of malignant brain tumors, including
brain tumor stem cells. J Neurosci Res. 86:48–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yoshimoto K, Ma X, Guan Y, Mizoguchi M,
Nakamizo A, Amano T, Hata N, Kuga D and Sasaki T: Expression of
stem cell marker and receptor kinase genes in glioblastoma tissue
quantified by real-time RT-PCR. Brain Tumor Pathol. 28:291–296.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakano I, Paucar AA, Bajpai R, Dougherty
JD, Zewail A, Kelly TK, Kim KJ, Ou J, Groszer M, Imura T, et al:
Maternal embryonic leucine zipper kinase (MELK) regulates
multipotent neural progenitor proliferation. J Cell Biol.
170:413–427. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cancer Genome Atlas Network: Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma XJ, Dahiya S, Richardson E, Erlander M
and Sgroi DC: Gene expression profiling of the tumor
microenvironment during breast cancer progression. Breast Cancer
Res. 11:R72009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Richardson AL, Wang ZC, De Nicolo A, Lu X,
Brown M, Miron A, Liao X, Iglehart JD, Livingston DM and Ganesan S:
X chromosomal abnormalities in basal-like human breast cancer.
Cancer Cell. 9:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Desmedt C, Piette F, Loi S, Wang Y,
Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y,
d'Assignies MS, et al: Strong time dependence of the 76-gene
prognostic signature for node-negative breast cancer patients in
the TRANSBIG multicenter independent validation series. Clin Cancer
Res. 13:3207–3214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hatzis C, Pusztai L, Valero V, Booser DJ,
Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, et
al: A genomic predictor of response and survival following
taxane-anthracycline chemotherapy for invasive breast cancer. JAMA.
305:1873–1881. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmidt M, Böhm D, von Törne C, Steiner E,
Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H and Gehrmann M: The
humoral immune system has a key prognostic impact in node-negative
breast cancer. Cancer Res. 68:5405–5413. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM,
Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu
J, et al: Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Esserman LJ, Berry DA, Cheang MC, Yau C,
Perou CM, Carey L, DeMichele A, Gray JW, Conway-Dorsey K, Lenburg
ME, et al: Chemotherapy response and recurrence-free survival in
neoadjuvant breast cancer depends on biomarker profiles: Results
from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast
Cancer Res Treat. 132:1049–1062. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Lee YM, Baitsch L, Huang A, Xiang
Y, Tong H, Lako A, Von T, Choi C, Lim E, et al: MELK is an
oncogenic kinase essential for mitotic progression in basal-like
breast cancer cells. Elife. 3:e017632014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Soldani C and Scovassi AI:
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update.
Apoptosis. 7:321–328. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murphy CS, Meisner LF, Wu SQ and Jordan
VC: Short- and long-term estrogen deprivation of T47D human breast
cancer cells in culture. Eur J Cancer Clin Oncol. 25:1777–1788.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gray D, Jubb AM, Hogue D, Dowd P, Kljavin
N, Yi S, Bai W, Frantz G, Zhang Z, Koeppen H, et al: Maternal
embryonic leucine zipper kinase/murine protein serine-threonine
kinase 38 is a promising therapeutic target for multiple cancers.
Cancer Res. 65:9751–9761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davezac N, Baldin V, Blot J, Ducommun B
and Tassan JP: Human pEg3 kinase associates with and phosphorylates
CDC25B phosphatase: a potential role for pEg3 in cell cycle
regulation. Oncogene. 21:7630–7641. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mils V, Baldin V, Goubin F, Pinta I, Papin
C, Waye M, Eychene A and Ducommun B: Specific interaction between
14-3-3 isoforms and the human CDC25B phosphatase. Oncogene.
19:1257–1265. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Forrest A and Gabrielli B: Cdc25B activity
is regulated by 14-3-3. Oncogene. 20:4393–4401. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seong HA, Gil M, Kim KT, Kim SJ and Ha H:
Phosphorylation of a novel zinc-finger-like protein, ZPR9, by
murine protein serine/threonine kinase 38 (MPK38). Biochem J.
361:597–604. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seong HA, Kim KT and Ha H: Enhancement of
B-MYB transcriptional activity by ZPR9, a novel zinc finger
protein. J Biol Chem. 278:9655–9662. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Joaquin M and Watson RJ: Cell cycle
regulation by the B-Myb transcription factor. Cell Mol Life Sci.
60:2389–2401. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tao D, Pan Y, Lu H, Zheng S, Lin H, Fang H
and Cao F: B-myb is a gene implicated in cell cycle and
proliferation of breast cancer. Int J Clin Exp Pathol. 7:5819–5827.
2014.PubMed/NCBI
|
|
32
|
Zhang X, Tang N, Hadden TJ and Rishi AK:
Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta.
1813:1978–1986. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hay N: Interplay between FOXO, TOR, and
Akt. Biochim Biophys Acta. 1813:1965–1970. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Medema RH, Kops GJ, Bos JL and Burgering
BM: AFX-like Forkhead transcription factors mediate cell-cycle
regulation by Ras and PKB through p27kip1. Nature. 404:782–787.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gu C, Banasavadi-Siddegowda YK, Joshi K,
Nakamura Y, Kurt H, Gupta S and Nakano I: Tumor-specific activation
of the C-JUN/MELK pathway regulates glioma stem cell growth in a
p53-dependent manner. Stem Cells. 31:870–881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim KH, Young BD and Bender JR:
Endothelial estrogen receptor isoforms and cardiovascular disease.
Mol Cell Endocrinol. 389:65–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
